This is a page where we will gather key documents we’re aware of about extending the use of naloxone in the community. We hope it is a resource for policy makers, providers and campaigners.
NAG England’s Key Facts – 10 important facts on naloxone for commissioners and providers.
- Take home naloxone reduces death due to opioid overdose
- Issuing naloxone doesn’t encourage heroin use
- Having naloxone and the relevant training encourages people to phone an ambulance
- Naloxone can be administered by the public while awaiting the arrival of professional assistance
- Naloxone is unlikely to harm others even if used by mistake
- Issuing naloxone to people who are no longer using opioids (for example, leaving rehab) is a protective action
- Risk of opioid overdose and what can be done to mitigate this risk is a matter of concern for anyone involved with the welfare of people who use opioids
- The training is quick and simple to deliver
- The cost is minimal, especially when compared to the clear benefits
- This isn’t just a new, ‘trendy’ drug treatment intervention
Download a customisable version of the above presentation – NAG Presentation
National and international evidence
- The Advisory Council on the Misuse of Drugs review of naloxone to assess if it should be more widely available in the UK.
- PHE advice for commissioners and providers on the provision of take-home naloxone for reversing overdose in people who use heroin and other opiates, now and following legislative change in October 2015 to make naloxone more readily available.
- World Health Organisation guidelines recommend that people who are likely to witness an opioid overdose, including people who use opioids, and their family and friends should be given access to naloxone and training in its use so that they can respond to opioid overdose in an emergency if a medical response is not available.
- European Monitoring Centre for Drugs and Drug Addiction review of evidence from the 21 studies which shows that educational and training interventions for peers and family members, complemented by take-home naloxone, may help decrease overdose-related mortality.